Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 2—February 2002
Research

Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada

David P. Speert*, Deborah Henry*, Peter Vandamme†, Mary Corey‡, and Eshwar Mahenthiralingam*
Author affiliations: *University of British Columbia and Children’s and Women’s Health Centre of British Columbia, Vancouver, British Columbia, Canada; †University of Ghent, Ghent, Belgium; ‡The Hospital for Sick Children, Toronto, Ontario, Canada

Main Article

Table 4

Number of cystic fibrosis patients infected with Burkholderia cepacia complex genomovar III RAPD strain type, by Canadian province

Province RAPD strain type
01 02 04 06 Other
(BCESM+)a
British Columbia 9 11 16 7 10 (5)
Alberta 2 14 16 0 0
Manitoba 0 1 1 0 1 (0)
Saskatchewan 0 0 0 0 0
Ontario 1 223 2 0 7 (5)
Quebec 5 7 1 0 2 (2)
Prince Edward Island 0 0 0 0 0
New Brunswick 0 0 2 0 1 (0)
Nova Scotia 0 2 12 0 4 (0)
Newfoundland
 0
 13
 0
 0
 0
Total 17 271 50 7 25 (12)

aNumber of patients whose isolates had Burkholderia cepacia epidemic strain marker (BCESM ) in the category “other genomovar III RAPD strain types”. Strain types 01, 02, 04, and 06 all encoded BCESM. RAPD = random amplified polymorphic DNA.

Main Article

Page created: April 18, 2012
Page updated: April 18, 2012
Page reviewed: April 18, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external